Late AppLovin After 1,428% Run: Is It Still a Buy?
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articles
The Number That Sets Record on AI Chip Demand: $75B
NVIDIA posted a record-breaking $75.25 billion in Data Center revenue for its fiscal Q1 2027, a 92% year-over-year su...
Amazon Spending 200m This Year: What It Means for Investors
Amazon lays out a multi-year AI and infrastructure push with a roughly $200 billion capex plan for 2026. Investors we...
Dividend Portfolio That Cover San Francisco Costs in 2026
With San Francisco home prices and daily expenses on the rise, investors are eyeing a dividend portfolio that cover l...
Interest National Debt Costs Now Outpace Medicare 2026
New fiscal data show that the cost of servicing the national debt is on track to exceed Medicare spending this year, ...
Applied Optoelectronics Rallies, Lumentum Rises on AI Optics Push
Applied Optoelectronics and Lumentum surged as Texas expansion plans lift demand for AI optics components, boosting r...
Nasdaq Income ETFs 2026: GPIQ Fee Advantage Sparks Debate
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
These Bank Earnings Have Shifted the Market Outlook
Five leading U.S. lenders posted stronger-than-expected quarterly results, challenging fears of a slowing economy and...
Hidden Cost: $350,000 Annuity Guarantees $2,200 a Month
A popular SPIA offers $2,200 monthly from a $350,000 lump sum, yet the contract hides key costs: fixed payments, loss...
Developing Rules Crypto. Here's Why Investors Should Watch
Regulators are advancing new crypto rules that could change trading, custody, and enforcement. This guide breaks down...
Planet Labs Sells Company: What Investors Should Know
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
Here's Vertex Willing Premium: Inside the Crinetics Deal
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...